# Brown & Brown, Inc.: overview

BRO · NYSE · CIK 79282 · [Financials](/sectors/financials.md) · fiscal year ends Jan 19

Pages: [Overview](/companies/bro.md) · [Financials](/companies/bro/financials.md) · [Filings](/companies/bro/filings.md) · [Insiders](/companies/bro/insiders.md)

Latest reported revenue: [$1.68bn](/filings/0001193125-26-318251.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 27, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-318251).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,186](/filings/0001193125-25-251811.md) | [1,183 d](/filings/0001193125-26-046984.md) | [1,404](/filings/0001193125-26-182389.md) | [1,285](/filings/0001193125-26-318251.md) | [1,606](/filings/0001193125-25-251811.md) | [1,607 d](/filings/0001193125-26-046984.md) | [1,901](/filings/0001193125-26-182389.md) | [1,676](/filings/0001193125-26-318251.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [19.7%](/filings/0001193125-25-251811.md) | [17.8% d](/filings/0001193125-26-046984.md) | [23.6%](/filings/0001193125-26-182389.md) | [18.0%](/filings/0001193125-26-318251.md) | [14.1%](/filings/0001193125-25-251811.md) | [16.4% d](/filings/0001193125-26-046984.md) | [22.4%](/filings/0001193125-26-182389.md) | [17.2%](/filings/0001193125-26-318251.md) |
| Diluted EPS | $ per share | [0.81](/filings/0001193125-25-251811.md) | not reported | [1.15](/filings/0001193125-26-182389.md) | [0.78](/filings/0001193125-26-318251.md) | [0.68](/filings/0001193125-25-251811.md) | not reported | [1.06](/filings/0001193125-26-182389.md) | [0.84](/filings/0001193125-26-318251.md) |
| Free cash flow | $m | [417 d](/filings/0001193125-25-251811.md) | [341 d](/filings/0001193125-26-046984.md) | [196](/filings/0001193125-26-182389.md) | [310 d](/filings/0001193125-26-318251.md) | [452 d](/filings/0001193125-25-251811.md) | [424 d](/filings/0001193125-26-046984.md) | [241](/filings/0001193125-26-182389.md) | [329 d](/filings/0001193125-26-318251.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,051](/filings/0000950170-24-018890.md) | [3,573](/filings/0000950170-25-019039.md) | [4,257](/filings/0001193125-26-046984.md) | [4,805](/filings/0001193125-26-046984.md) | [5,902](/filings/0001193125-26-046984.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [19.2%](/filings/0000950170-24-018890.md) | [18.8%](/filings/0000950170-25-019039.md) | [20.5%](/filings/0001193125-26-046984.md) | [20.7%](/filings/0001193125-26-046984.md) | [17.9%](/filings/0001193125-26-046984.md) |
| Diluted EPS | $ per share | [2.07](/filings/0000950170-24-018890.md) | [2.37](/filings/0000950170-25-019039.md) | [3.05](/filings/0001193125-26-046984.md) | [3.46](/filings/0001193125-26-046984.md) | [3.16](/filings/0001193125-26-046984.md) |
| Free cash flow | $m | [764](/filings/0000950170-24-018890.md) | [829](/filings/0000950170-25-019039.md) | [941](/filings/0001193125-26-046984.md) | [1,092](/filings/0001193125-26-046984.md) | [1,382](/filings/0001193125-26-046984.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bro/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.42bn | 22,113,344 |  | Added +196,597 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.22bn | 18,941,212 |  | Added +19,972 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.18bn | 18,405,749 |  | Added +2,355,053 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $1.01bn | 15,721,830 |  | Added +113,110 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $938.6m | 14,631,444 |  | Added +44,968 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $931.1m | 14,514,119 |  | Added +737,657 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $928.0m | 14,465,915 |  | Reduced −2,028,007 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $752.3m | 11,727,514 |  | Added +2,904,352 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $752.3m | 11,727,514 |  | Added +2,904,352 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $526.0m | 8,230,737 |  | Added +92,584 |

## Recent filings

[All 1,124 filings](/companies/bro/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 17:03 ET | [8-K](/filings/0001193125-26-432142.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-432142 |
| 2026-10-22 | 17:00 ET | [8-K](/filings/0001193125-26-429079.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-429079 |
| 2026-09-10 | 21:17 ET | [8-K](/filings/0001193125-26-386867.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-386867 |
| 2026-08-10 | 06:45 ET | [8-K](/filings/0001193125-26-341162.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-341162 |
| 2026-07-27 | 17:06 ET | [10-Q](/filings/0001193125-26-318251.md) | Quarterly report, period 2026-06-30 | 0001193125-26-318251 |
| 2026-07-27 | 17:03 ET | [8-K](/filings/0001193125-26-318245.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318245 |
| 2026-06-05 | 17:00 ET | [8-K](/filings/0001193125-26-259864.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-259864 |
| 2026-05-07 | 17:00 ET | [8-K](/filings/0001193125-26-212338.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-212338 |
| 2026-04-27 | 17:12 ET | [10-Q](/filings/0001193125-26-182389.md) | Quarterly report, period 2026-03-31 | 0001193125-26-182389 |
| 2026-04-27 | 17:08 ET | [8-K](/filings/0001193125-26-182375.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-182375 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-046984.md), filed Feb 12, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/84ee1de3-f2b2-44ae-a7d1-66489c4bda2f)

## About the filer

- CIK: 79282
- Tickers: BRO
- Exchange: NYSE
- SIC code: 6411 Insurance Agents, Brokers & Service
- State of incorporation: FL
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:06 ET. No prices; not investment advice.